Cargando…
Ruthenium brachytherapy for uveal melanoma – single institution experience
PURPOSE: The aim of this study was to report on results of uveal melanoma treatment with ruthenium-106 ((106)Ru) brachytherapy with long-term follow-up, in terms of local tumor control, eye retention rate, radiation retinopathy, and patients’ survival. MATERIAL AND METHODS: Medical records of patien...
Autores principales: | Rospond-Kubiak, Iwona, Wróblewska-Zierhoffer, Marta, Twardosz-Pawlik, Hanna, Kocięcki, Jarosław |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808002/ https://www.ncbi.nlm.nih.gov/pubmed/29441099 http://dx.doi.org/10.5114/jcb.2017.72606 |
Ejemplares similares
-
Ruthenium brachytherapy for iris melanoma
por: Zwolin´ska, Emilia, et al.
Publicado: (2023) -
Ruthenium brachytherapy for intraocular growth of a conjunctival squamous cell carcinoma: a case report
por: Rospond-Kubiak, Iwona, et al.
Publicado: (2018) -
Primary uveal lymphoma effectively managed with oral chlorambucil: a case report
por: Rospond-Kubiak, Iwona, et al.
Publicado: (2013) -
Brachytherapy of Uveal Melanomas with Ruthenium-106 Plaques
por: Belaïd, Asma, et al.
Publicado: (2016) -
Small-cell lung carcinoma metastasis to the iris – case presentation
por: Nikratowicz, Danuta, et al.
Publicado: (2013)